繁體版 / 簡體版
 
R&D PORTFOLIO
/ MS-20(CHEMO YOUNG)

MS-20(CHEMO YOUNG)

Indication
Ameliorating fatique and appetite loss associated with cancer chemotheraphy
Ingredient
Organic soybean and probiotics fermentation products
Dosage
4ml twice daily on an empty stomach, after diluting in 100ml of warm water
Status
Approved by Ministry of Health and Welfare(MOHW):available in Taiwan Market
Mechanism
Immune restoration and regulation
  • MS-20 is a mixture of soybean fermentation metabolites which is produced in strictly controlled fermenter and with carefully chosen microorganisms that mimics human intestinal environment.
  • The manufacturing and R&D procedures of Chemo Young follow the international regulations.
  • MS-20 was approved as new drug by MOHW in 2011.
  • MS-20 acts as an immunemodulator and probiotics to improve immunity and inhibit tumor growth.
  • MS-20 is the first and the only oral medication for ameliorating fatigue and appetite loss in patients receiving chemotherapy and thus improve the quality of life.
  • The estimated market of MS-20 in Taiwan will be around 4.5 billion TWD as every year there will be 90,000 new cancer patients. Worldwide, the number of cancer patients will reach 1.4 millions and the medical needs will be over 20 billion USD every year.

MS-20 has also been shown to be anti-PD-1 booster in mice cancer model by increasing effector cytotoxic T cells and inhibiting tumor growth, reducing myeloid-derived suppressor cells (MDSCs).


陕西快乐十分中奖技巧 大众麻将在线游戏 天天彩选3走势图 安徽11选五5开奖结果 微乐贵州捉鸡麻将 现金广东麻将棋牌官网 298棋牌游戏下载 浙江体彩6十1开奖结果 山西十一选五遗漏 单机捕鱼游戏下载 闲来贵州麻将最新版本 乐乐安徽麻将微信版 五分彩有什么技巧 陕西快乐十分技巧 广西11选5有软件买的吗 全民欢乐捕鱼辅助软件 下载琼崖海南麻将2019